Skip to content

Feasibility and Acceptability of an Web-based Physical Activity Program, for Those Diagnosed With Lung Cancer.

Feasibility and Acceptability of an Online Web-based Physical Activity Program, for Those Living With and Beyond Lung Cancer.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05121259
Enrollment
18
Registered
2021-11-16
Start date
2021-11-22
Completion date
2022-08-11
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Survivorship

Keywords

Physical Activity, Exercise, Digtial Technology

Brief summary

Lung cancer is a life changing disease which can cause negative effects on an individual's ability to perform daily tasks and their quality of life (QoL). Lung cancer is the third most common cancer in the UK and is estimated affects approximately 33,000 individuals per year. The most common side effects from lung cancer and treatments are breathlessness, fatigue, nausea, diarrhoea, and depression. Those living beyond cancer often suffer from extreme feelings of isolation and have increased chance of cardiovascular disease and diabetes. Physical activity is a vital component of the prevention and management of cancer. Being active can improve one's physical health (ability to carry out tasks of daily living and breathlessness) and emotional wellbeing (feelings of depression and isolation). Electronic platforms (websites and mobile applications) are increasingly popular within developing nations, particularly with products that aim to increase and keep track of physical activity. Though, literature suggests older adults prefer websites opposed to mobile applications. Online delivery of physical activity could be highly beneficial for patients living with and beyond cancer, reducing the location-based inequality of those who can not attend face-to-face programmes, allowing individuals to carry out a session whenever they can, in the comfort of their own home. Exploring how those living with and beyond lung cancer use a website and investigating the feasibility and acceptability on an online platform which aims to provide tailored physical activity programs will provide fundamental data and possible supporting data for a randomised controlled trail (RCT).

Interventions

OTHERExerciseGuide Intervention Group

The single group which will be given access to the eight-week ExerciseGuide UK website containing a tailored physical activity programme and supportive and educational resources.

Sponsors

Hull University Teaching Hospitals NHS Trust
CollaboratorOTHER_GOV
University of Hull
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single group feasibility study. Upon obtaining informed consent, participants will be allocated to the intervention group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be 18 years of age or older. * Have had a lung cancer diagnosis. * Be able to speak and read in English. * Willing and able to provide informed consent. * Have internet connectivity. * Access to a laptop, computer, or smart device to access the web-based platform.

Exclusion criteria

* Psychological or linguistic inability to provide informed consent. * Physical or psychological impairments which prevent or inhibit participation in physical activity. Examples include: * Uncontrolled atrial fibrillation * Abdominal aortic aneurysm (AAA) * Recent heart attack (less than one year) * Recent stroke (less than one year) * Psychiatric disorder * Those who lack capacity under the Mental Capacity Act 2005 (MCA).

Design outcomes

Primary

MeasureTime frameDescription
The recruitment rate (Website Feasibility)39 weeksThe recruitment rate will be established by the number of potential participants approached and how many agree to participate. The recruitment rate will be provided in a factorial or percentage format.
The retention rate (Website Feasibility)39 weeksThe retention rate will be given based on the initial value of those who provide consent vs those who complete the eight-week intervention. The retention rate will be provided in a factorial or percentage format.
Participant Satisfaction (Acceptability)39 weeksThe metric which will be assessed to explore acceptability will be satisfaction. Satisfaction will be explored in four approaches: 1. Satisfaction via research team developed questionnaire. The questionnaire will be a five-point Likert scale reporting method from Strongly Agree to Strongly Disagree in relation to their agreement to statements. 2. Real-time open-ended feedback will be collected upon the first completion of a module 3. Systems Usability Scale (Brooke, 1986). The 10-item questionnaire will provide a five-point Likert scale reporting method from Strongly Agree to Strongly Disagree in relation to their agreement to statements. 4. A selection of participants based on recruitment will be asked to take part in an interview to further explore satisfaction and acceptability. An interview guide covering the experience of using the website, concerns, and suggested revisions will be followed. The interviews will be transcribed verbatim and analysed.

Secondary

MeasureTime frameDescription
BreathlessnessEight weeksBreathlessness will be assessed using the EORTC QLQ-C30 (version 3). The scoring value will be provided in a numerical value from the questionnaire and compared at baseline and study completion. The questionnaire used a four-point Likert scale reporting method 1, Not at all; 2, A Little; 3, Quite a bit; and 4, Very much in relation to their agreement to statements.
Physical FunctioningEight weeksPhysical functioning will be assessed using the EORTC QLQ-C30 (version 3). The scoring value will be provided in a numerical value from the questionnaire and compared at baseline and study completion. The questionnaire used a four-point Likert scale reporting method 1, Not at all; 2, A Little; 3, Quite a bit; and 4, Very much in relation to their agreement to statements.
Quality of Life (or Global Health Status) will be assessed using the EORTC QLQ-C30 (version 3).Eight weeksQuality of Life (or Global Health Status) will be assessed using the EORTC QLQ-C30 (version 3). The scoring value will be provided as a numerical value from the questionnaire and compared at baseline and study completion. The questionnaire used a four-point Likert scale reporting method 1, Not at all; 2, A Little; 3, Quite a bit; and 4, Very much in relation to their agreement to statements. Two questions (Q29 ad Q30) use a seven-point Likert scale reporting method ranging from 1 (Very poor) to 7 (Excellent).
Hospital Anxiety Depression Scale (HADS)Eight weeksHospital Anxiety Depression Scale (HADS) will be used pre-and post-study to explore changes in anxiety and depression. The HADS assigns statements to a numerical value (between 0 and 3) which is selected in agreement to the statement. These scores are totalled providing an overall score for both Anxeity and Depression.
Emotional FunctioningEight weeksEmotional functioning will be assessed using the EORTC QLQ-C30 (version 3). The scoring value will be provided in a numerical value from the questionnaire and compared at baseline and study completion.
Fatigue will be assessed using the EORTC QLQ-C30 (version 3Eight weeksFatigue will be assessed using the EORTC QLQ-C30 (version 3). The scoring value will be provided in a numerical value from the questionnaire and compared at baseline and study completion. The questionnaire used a four-point Likert scale reporting method 1, Not at all; 2, A Little; 3, Quite a bit; and 4, Very much in relation to their agreement to statements.
Pain will be assessed using the EORTC QLQ-C30 (version 3)Eight weeksPain will be assessed using the EORTC QLQ-C30 (version 3). The scoring value will be provided in a numerical value from the questionnaire and compared at baseline and study completion. The questionnaire used a four-point Likert scale reporting method 1, Not at all; 2, A Little; 3, Quite a bit; and 4, Very much in relation to their agreement to statements.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026